Saturday, September 6, 2025
  • Advertise
  • Recruitment
  • Contact us:
  • Register
Irish Pharmacy News
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
Irish Pharmacy News

Pfizer Announces Availability of XELJANZ®▼ (tofacitinib citrate) Prolonged-Release Tablets for Rheumatoid Arthritis

IPN by IPN
23 October 2020
in Product News
0
Pfizer Announces Availability of XELJANZ®▼ (tofacitinib citrate) Prolonged-Release Tablets for Rheumatoid Arthritis

Pfizer Healthcare Ireland has today announced the availability of XELJANZ® (tofacitinib citrate) 11mg prolonged-release tablets for the once-daily treatment of moderate to severe rheumatoid arthritis (RA) in combination with methotrexate in patients who have had an inadequate response or intolerance to methotrexate or other DMARDs.

Commenting on the announcement, Michael Stewart, I&I Lead Ireland, Pfizer Healthcare Ireland said; “Pfizer continues to be an innovator in inflammation and immunology. The introduction of XELJANZ 11mg once daily tablets provides physicians with another treatment option for rheumatoid arthritis patients who may prefer an oral once-daily treatment. Xeljanz also has a close connection here in Ireland as it is manufactured in our Ringaskiddy site in Cork.”

Previous Post

Canice’s Store to Store Cycle Challenge

Next Post

Boots Ireland launch Annual Night Walk in Aid of The Irish Cancer Society’s Night Nurses

Next Post

Boots Ireland launch Annual Night Walk in Aid of The Irish Cancer Society’s Night Nurses

Four UCD researchers receive ERC Starting Grants for groundbreaking research projects

Four UCD researchers receive ERC Starting Grants for groundbreaking research projects

4 September 2025
EUROPEAN COMMISSION AUTHORISES TWICE-YEARLY LENACAPAVIR FOR HIV  PREVENTION (brand name YEYTUO®) 

EUROPEAN COMMISSION AUTHORISES TWICE-YEARLY LENACAPAVIR FOR HIV  PREVENTION (brand name YEYTUO®) 

4 September 2025
Back to school: Expert guidance from the HSE for a smoother start to the school year

Back to school: Expert guidance from the HSE for a smoother start to the school year

22 August 2025

RECOMMENDED NEWS

McCabes Pharmacy launches a new fast, confidential and comprehensive Blood Testing Service – No Referral Needed!

McCabes Pharmacy launches a new fast, confidential and comprehensive Blood Testing Service – No Referral Needed!

1 month ago

Arthritis Ireland launches free online courses to support people during Covid-19

5 years ago

Ministers for Health announce new Jigsaw sites for Wicklow and Tipperary

6 years ago

HSE Web Portal on disability day services now live

5 years ago
Tweets by Irish_PharmNews

Quick links

  • About
  • Advertise
  • Careers
  • Contact us

Other info

  • Contact us
  • Register for Digital Magazines
  • Privacy Policy
  • About
  • Advertise
  • Careers
  • Contact us

© 2024 IPN

  • Login

    Forgot password? | Register

    Register

    Registration confirmation will be emailed to you.

    Login | Forgot password?

    Reset Password

    Please enter your username or email address. You will receive a link to create a new password via email.

    Login

Login

Register

Forgotten Password?

Register | Lost your password?
| Back to Login
No Result
View All Result
  • News
  • Learning
  • Other
    • Conferencing
    • Developments
    • Product News
    • Profiles
    • Research
  • Digital Magazines (IPN Online Issues Older Issue Tabs)
  • Awards

© 2024 IPN